Gufic Biosciences Limited (BOM:509079)
India · Delayed Price · Currency is INR 381.55
+3.30 (0.87%)
At close: Jul 27, 2026
Gufic Biosciences Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 9,440 | 9,440 | 8,198 | 8,067 | 6,906 | 7,792 |
Revenue Growth | 15.15% | 15.15% | 1.63% | 16.80% | -11.36% | 59.76% |
Gross Profit Gross Profit Growth | 5,228 | 5,228 | 4,378 | 4,080 | 3,513 | 3,585 |
Operating Income Operating Income Growth | 1,205 | 1,205 | 1,173 | 1,326 | 1,153 | 1,291 |
Net Income Net Income Growth | 642.15 | 642.15 | 696.5 | 861.36 | 797.05 | 958.4 |
Earnings Per Share EPS Growth | 6.40 | 6.40 | 6.95 | 8.74 | 8.22 | 9.89 |
EPS Growth | -7.86% | -7.86% | -20.53% | 6.33% | -16.85% | 116.80% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 6,545 | 7,185 | 5,837 | 7,070 |
Africa Africa Growth | 241.44 | 98.75 | 134.14 | 90.89 |
Asia Asia Growth | 495.54 | 363.02 | 511.62 | 281.23 |
Europe Europe Growth | 617.81 | 296.4 | 294.23 | 255.21 |
North America North America Growth | 97.45 | 102.38 | 116.19 | 83.53 |
Australia Australia Growth | 6.25 | 2.02 | 5.36 | 4.06 |
South America South America Growth | 194.7 | 18.89 | 7.5 | 6.24 |
Total Total Growth | 8,198 | 8,067 | 6,906 | 7,792 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 762.17 | 762.17 | 157.23 | 11.37 | 286.02 | 116.08 |
Total Debt Total Debt Growth | 4,048 | 4,048 | 3,362 | 3,329 | 3,342 | 643.87 |
Net Cash (Debt) Net Cash Growth | -3,285 | -3,285 | -3,205 | -3,318 | -3,056 | -527.79 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -32.74 | -32.74 | -31.96 | -33.68 | -31.52 | -5.44 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 449.68 | 449.68 | 1,226 | -74.57 | -265.87 | 1,062 |
Capital Expenditures CapEx Growth | -311.81 | -311.81 | -755.26 | -1,127 | -1,876 | -874.53 |
Free Cash Flow Free Cash Flow Growth | 137.87 | 137.87 | 470.42 | -1,202 | -2,142 | 187.86 |
Free Cash Flow Growth | -70.69% | -70.69% | - | - | - | -74.90% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 55.38% | 55.38% | 53.41% | 50.58% | 50.87% | 46.01% |
Operating Margin | 12.77% | 12.77% | 14.31% | 16.44% | 16.70% | 16.57% |
Pretax Margin | 9.17% | 9.17% | 11.48% | 14.34% | 15.45% | 16.28% |
Profit Margin | 6.80% | 6.80% | 8.50% | 10.68% | 11.54% | 12.30% |
FCF Margin | 1.46% | 1.46% | 5.74% | -14.89% | -31.01% | 2.41% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.100 | 0.100 | 0.100 | 0.100 | 0.100 | 0.100 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 0.03% | 0.04% | 0.03% | 0.03% | 0.05% | 0.04% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 59.62 | 42.88 | 48.44 | 32.96 | 22.70 | 25.18 |
P/FCF Ratio | 277.54 | 199.71 | 71.72 | - | - | 128.44 |
PS Ratio | 4.05 | 2.92 | 4.12 | 3.52 | 2.62 | 3.10 |